Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP2431741

Methods for determining active ingredients in pro-drug PEG protein conjugates with releasable PEG reagents (in vitro de-pegylation)

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    20.10.2009
  • EP published:
    21.8.2013
  • EP application number:
    11009919.9
  • Max expiry date:
    19.10.2029
  • Title:
    Methods for determining active ingredients in pro-drug PEG protein conjugates with releasable PEG reagents (in vitro de-pegylation)

Timeline

Today
20.10.2009EP application
21.8.2013EP Publication

Owner

  • Name:
    Baxter International Inc
  • Address:
    One Baxter Parkway, 60015, Deerfield, IL, US
  • Name:
    Baxter Healthcare SA
  • Address:
    Thurgauerstrasse 130, 8152, Glattpark (Opfikon), CH
  • Name:
    Nektar Therapeutics
  • Address:
    455 Mission Bay Boulevard South, Suite 100, 94158, San Francisco, CA, US

Inventor

  • Name:
    Varadi, Katalin
  • Address:
    Vienna, AT
  • Name:
    Schrenk, Gerald
  • Address:
    Vienna, AT
  • Name:
    Rottensteiner, Hanspeter
  • Address:
    Vienna, AT
  • Name:
    Turecek, Peter
  • Address:
    Klosterneuburg, AT
  • Name:
    Weber, Alfred
  • Address:
    Vienna, AT
  • Name:
    Anderle, Heinz
  • Address:
    Klosterneuburg, AT
  • Name:
    Culbertson, Sean M.
  • Address:
    Gurley AL, US
  • Name:
    Fang, Zhihao
  • Address:
    MadisonAL, US
  • Name:
    Zappe, Harold
  • Address:
    Harvest, US
  • Name:
    Zhang, Ping
  • Address:
    Millbrae CA, US
  • Name:
    Bossard, Mary J.
  • Address:
    Madison AL, US

Priority

  • Number:
    10725708 P
  • Date:
    21.10.2008
  • Country:
    US
  • Number:
    24263409 P
  • Date:
    15.9.2009
  • Country:
    US

Classification

  • Categories:
    G01N 33/542, G01N 33/58, G01N 33/68, G01N 33/86

Upload documents